Back
ESC Premium Access

DETermination of the role of OXygen in suspected Acute Myocardial Infarction

Session: Hot Line: Late-Breaking Clinical Trials 2
Topic: Infarction acute phase STEMI
Speaker: Associate Professor R. Hofmann (Stockholm, SE)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Associate Professor Robin Hofmann

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

17 more presentations in this session

SPYRAL HTN OFF-MED Study

Speaker: Professor M. Boehm (Homburg, DE)

Access
Slides
Video
Thumbnail

Discussant review: SPYRAL HTN OFF-MED Study

Speaker: Professor B. Williams (London, GB)

Access
Slides
Video
Thumbnail

Panel discussion.

Access
Thumbnail

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor M. Ezekowitz (Philadelphia, US)

Access
Slides
Video
ESC TV
Thumbnail

Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor J. Nielsen (Aarhus, DK)

Access
Slides
Video
ESC TV
Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 2

Speakers: Associate Professor R. Hofmann, Professor M. Boehm, Professor B. Williams, Professor M. Ezekowitz, Professor J. Nielsen
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb